Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Tissue-of-origin (ORIGIN-PanCA○R) Profiling in Predicting Primary Site and Directing Therapy in Patients With Cancer of Unknown Primary: a Prospective Randomized Controlled Study

NCT03278600 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT03278600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03278600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Tissue-of-origin (ORIGIN-PanCA○R) Profiling in Predicting Primary Site and Directing Therapy in Patients With Cancer of Unknown Primary: a Prospective Randomized Controlled Study
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Completed
Start date
September 18, 2017
Completion date
March 18, 2021
Enrollment
182 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of unknown primary site